Aehr Test Systems (NASDAQ:AEHR) is a pioneering provider of semiconductor test and reliability screening equipment that plays a vital role in ensuring the performance and dependability of the world’s most advanced chips. Founded in 1977 and headquartered in Fremont, California, the company has spent over four decades developing cutting-edge solutions that address one of the most critical yet underappreciated aspects of chip manufacturing—burn-in testing. This process, which simulates accelerated aging conditions, is essential for identifying early-life failures in high-performance integrated circuits before they are deployed into mission-critical applications such as electric vehicles, data centers, aerospace systems, and now, artificial intelligence (AI) infrastructure. Aehr’s deep specialization in this area has made it a strategic partner for some of the largest and most technologically demanding customers in the semiconductor ecosystem.
Traditionally, Aehr made its mark in the silicon carbide (SiC) sector, which exploded in popularity due to its advantages in power efficiency, thermal conductivity, and durability for electric vehicles and industrial applications. Aehr’s FOX-XP wafer-level burn-in systems allowed customers to screen full wafers of SiC chips in parallel, greatly improving test throughput and reducing cost per device. The success of this platform cemented Aehr’s leadership in a niche but fast-growing segment of the power semiconductor industry. As demand for silicon carbide slowed in 2024 and 2025, the company strategically diversified its offerings and set its sights on one of the fastest-growing megatrends in technology: artificial intelligence.
With the global AI semiconductor market projected to exceed $600 billion by 2032, Aehr Test Systems recognized a critical opportunity to adapt and expand its platform. In 2025, the company acquired Incal Technology, a move that enabled it to offer a complementary high-power packaged part burn-in solution through its Sonoma systems. Together with its flagship FOX-XP wafer-level platform, Aehr now provides the industry’s only dual-stack solution for end-to-end reliability testing of AI processors. This is especially valuable to hyperscale data center operators and AI chip manufacturers who are building next-generation chips that run at extremely high power densities. Aehr’s combined wafer-level and packaged-part burn-in capabilities give customers a seamless workflow from early qualification to high-volume production, effectively locking in long-term partnerships and recurring revenue.
Aehr’s technology portfolio is protected by a series of proprietary innovations, including active thermal control, liquid-cooled testing environments, and scalable parallelism. These features are critical for AI chips, which often exceed 2000 watts of power per device and require rigorous screening to ensure reliability in real-world deployment. With orders from leading hyperscalers already in place and eight high-power systems shipping over a six-month period, Aehr is fast becoming a key enabler of AI infrastructure—offering the tools that ensure the chips of tomorrow can meet the extreme performance and reliability demands of data centers, robotics, and autonomous platforms.
The company’s expansion into new verticals does not stop at AI. Aehr is actively exploring opportunities in gallium nitride (GaN), NAND flash memory, and photonics—all of which require the type of high-throughput, high-precision test environments that Aehr specializes in. As chip complexity grows and the cost of failure rises, the market for reliability screening is only expected to expand. Aehr’s modular, scalable platforms are uniquely positioned to serve this need across multiple markets, providing a long runway for growth.
Despite some short-term softness in legacy markets like silicon carbide, Aehr remains financially sound. As of May 2025, the company reported a $26.5 million cash balance, a growing backlog of $16.3 million, and increasing AI-related revenues that are expected to become a more significant portion of total sales in fiscal 2026. By maintaining capital discipline while aggressively pursuing emerging opportunities, Aehr is balancing operational resilience with strategic innovation.
Aehr Test Systems may not be as widely known as the semiconductor giants it serves, but its impact on the industry is undeniable. By focusing on reliability, test efficiency, and enabling scalable production for next-generation technologies, Aehr plays an increasingly critical role in the semiconductor value chain. As AI, electric vehicles, and next-gen computing redefine the future, Aehr’s platforms will help ensure that the chips powering this future perform flawlessly from day one.
Capitalizing on the AI Semiconductor Gold Rush
The AI chip market was valued at over $60 billion in 2023 and is forecast to grow tenfold by 2032, driven by the proliferation of large language models, generative AI, edge computing, and advanced robotics. As AI chips become more powerful, they also become more prone to early-life failures due to thermal stress and power density. Burn-in testing, which subjects chips to accelerated stress conditions, is vital to identifying faulty units before deployment. Aehr Test Systems, through years of R&D and timely acquisitions, now stands as the only company globally offering both wafer-level burn-in (WLBI) and packaged part burn-in (PPBI) solutions specifically for high-power AI processors.
This dual-solution approach gives Aehr a unique strategic advantage. Its FOX-XP system enables entire wafers to be tested before they’re packaged, which reduces cost and time-to-market. Meanwhile, through its acquisition of Incal Technology, Aehr added the Sonoma system to its arsenal—delivering ultra-high-power packaged part burn-in testing designed specifically for cutting-edge AI chips. This one-two punch of WLBI and PPBI makes Aehr indispensable to AI chip manufacturers and hyperscalers alike, who require comprehensive reliability at every production stage.
CHECK THIS OUT: POET Technologies (POET) Delivers 1.6T Optical Innovation—Is a Massive Revenue Surge Next? and BigBear.ai (BBAI) is Flying Under the Radar—But Not for Long. Here’s Why Bulls Are Piling In.
Securing Hyperscaler Relationships and Future Revenue Streams
The value of Aehr’s end-to-end testing platform has already been validated by one of the world’s largest hyperscalers—a term that typically refers to companies like Amazon, Google, or Microsoft operating massive data centers. This customer not only adopted Aehr’s systems for AI chip production testing but also engaged the company to test its next-generation designs. Orders for eight Sonoma systems have already been placed, and these systems—capable of handling chips with power densities up to 2000 watts per device—are expected to ship within a six-month window.
These developments are more than one-off wins. They reflect a durable customer relationship, a lock-in effect created by Aehr’s ability to support qualification and mass production with the same platform. This streamlined path from prototype to rollout not only saves customers money but also makes switching to another provider a costly and inefficient alternative. Aehr’s CEO, Gayn Erickson, has emphasized that the combined WLBI and PPBI testing market for AI processors could surpass $100 million annually—and Aehr is strategically positioned to capture a significant portion of that.
Resilient Financials and Rising Backlog Amid Industry Headwinds
Aehr’s fiscal 2025 results reflect the typical growing pains of a company making an aggressive pivot into a high-growth vertical. The firm reported a GAAP net loss of $3.9 million, driven by restructuring costs and tax adjustments. However, the non-GAAP picture is much more optimistic: a $4.6 million profit and an effective backlog of $16.3 million, including sizable orders from its AI customer. In fact, AI-related revenue doubled in Q2 2025 compared to the previous year.
While silicon carbide—a market that once contributed over 90% of Aehr’s revenue—has experienced a slowdown, the diversification into AI chips, GaN, and flash memory has enabled Aehr to reduce dependency on any single vertical. The strategic shift from a SiC-heavy revenue model toward a balanced portfolio across multiple emerging technologies is a long-term win for the company. Aehr also ended the fiscal year with a cash balance of $26.5 million, ensuring it has the liquidity to weather short-term macro headwinds and invest in further expansion.
Proprietary Technology Creates a Durable Moat
At the heart of Aehr’s competitive edge is its proprietary technology, particularly the FOX-XP and Sonoma platforms. These systems allow testing of high-power chips at unprecedented scale and accuracy. The FOX-XP can test up to 18 wafers simultaneously, each delivering over 3500 watts of power, making it ideal for both silicon carbide and AI processors. The Sonoma system, now enhanced post-acquisition, is purpose-built for liquid-cooled PPBI and allows scalable thermal control—a crucial requirement for modern AI workloads.
This level of precision and scalability is rare in the semiconductor test industry. Moreover, Aehr’s modular platform design allows customers to scale their testing infrastructure without overhauling their entire process. This makes Aehr not just a vendor, but a long-term partner in the production ecosystem—resulting in strong customer retention and long-term revenue streams from recurring maintenance, upgrades, and future system orders.
Risks and Why They May Be Overstated
Despite Aehr’s strong positioning, the company is not immune to industry risks. The softening of demand in the silicon carbide market and ongoing uncertainty around tariffs could impact near-term sales. There is also the looming presence of larger semiconductor equipment manufacturers who may attempt to enter the burn-in testing market for AI chips. However, Aehr’s first-mover advantage, its established relationships with hyperscalers, and its dual WLBI and PPBI architecture provide a formidable defense against new entrants. Its financial discipline, including a strong cash position and lean operations, gives the company the runway needed to navigate short-term disruptions.
Importantly, while competitors are still refining their AI chip testing strategies, Aehr is already shipping systems, collecting revenue, and supporting real production environments. This operational lead time matters in a market defined by speed, precision, and technological complexity.
Investment Case: Small Cap, Big Potential
Aehr Test Systems may not yet command the valuation multiples of some AI chipmakers, but its role in the semiconductor supply chain is no less critical. As the only company currently providing both wafer and package-level burn-in for AI chips, Aehr occupies a defensible niche with massive upside potential. The company’s AI-related backlog, strategic customer wins, and rising market share in emerging segments such as GaN and flash memory all point to accelerating top-line growth in fiscal 2026 and beyond.
With more chip designers moving toward vertically integrated production and hyperscalers investing heavily in proprietary AI silicon, the need for precision testing will only intensify. Aehr’s unique combination of technology, customer integration, and operational scale positions it to benefit from this trend. As AI computing becomes the new gold rush of the 21st century, Aehr is the toolmaker quietly powering that revolution.
For investors looking to ride the wave of AI infrastructure—not through flashy megacaps, but through the critical enablers in the background—Aehr Test Systems represents a high-conviction, high-reward opportunity.
READ ALSO: MicroVision (MVIS): A Top Pick in Autonomous Tech Stocks and Innoviz (INVZ) May Be Severely Undervalued — Investors Shouldn’t Ignore This Stock.
